Tech Biotechnology: Majority of Developers Write Code and Use Machine Learning; Protein Engineering Is a Top Priority

Date:

Cradle, an innovative platform aiding scientists to create and program proteins, has recently conducted its first Biodeveloper survey in partnership with Bits in Bio, a global community devoted to developing software for scientists. The survey collected responses from more than 150 biodevelopers, offering a glimpse into the current landscape of the synthetic biology sector. The survey revealed that coding has become a critical skill for those working in biotech and many of these skills are self-taught. Moreover, Machine Learning has already been implemented by a majority of biodevelopers and is gaining more attention among scientists. Lastly, there is an obvious interest in protein engineering, with 71% of those surveyed already exploring or aiming to explore the subject.

Cradle is a business founded to simplify the designing and building of proteins. Therefore, the survey helped paint a picture of how biologists are utilizing technology in their work and what tools they are using. It is clear that coding and Machine Learning are playing an increasingly important role as the tools become more accessible. Furthermore, proteins are being seen as a potential solution to tackle many modern day issues, such as climate change and disease, with a notable interest from biodevelopers to explore this field.

Bits in Bio, through gathering feedback from the community, strives to advance communication between biodevelopers and help people learn best practices. With AI technologies evolving continuously, it is essential to navigate the intersection between software and science effectively. On the whole, the first BioDeveloper survey gave a lot of insight into the current trends of the synthetic biology sector.

See also  Google Launches AI-Driven 'Threat Intelligence' Solution for Cybersecurity Protection

From Cradle Bio B.V. is a company specialized in simplifying the designing and programming of proteins. Founded by Stef van Grieken, the company creates easy-to-use platforms that allow users to employ existing technologies to generate complex protein designs. Their ambition is to make custom protein design and programming accessible to all.

Nicholas Larus-Stone, the creator of Bits in Bio and CEO of Sphinx Bio, is dedicated to helping both scientists and developers make the most of the intersection between software and science. Through providing a global community devoted to the development of software for science, he hopes to facilitate greater communication amongst biodevelopers through feedback and results from the community.

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.